Ex-FDA chief Gottlieb sees investment opportunity in ‘unloved’ antibiotics
As a private investor, former
U.S. Food and Drug Administration Commissioner Scott Gottlieb is
focused on an area where few have found success in recent years:
developing new antibiotics.